BioCanRx: Biotherapeutics For Cancer Treatment /BioCanRx: Biothérapies pour le traitement du cancer: federal grants and contributions: 1 agreements; $38.0M value; 1 departments; 1 programs.
Assay record ASY-CA-0O18G7M1X2 · Cite as: Assay Systems, “BioCanRx: Biotherapeutics For Cancer Treatment /BioCanRx: Biothérapies pour le traitement du cancer: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/biocanrx-biotherapeutics-for-cancer-treatment-biocanrx-bioth-rapies-pour-le-traitement-du-cancer/
BioCanRx was established in 2015 as a federally-funded NCE to develop, manufacture, and clinically test new cancer immunotherapies.
All grants from Innovation, Science and Economic Development Canada
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.